Home/Filings/4/0000899243-20-014472
4//SEC Filing

Jackson Jonathan 4

Accession 0000899243-20-014472

CIK 0001383701other

Filed

May 27, 8:00 PM ET

Accepted

May 28, 7:51 PM ET

Size

6.0 KB

Accession

0000899243-20-014472

Insider Transaction Report

Form 4
Period: 2020-05-26
Jackson Jonathan
Director10% Owner
Transactions
  • Other

    Common Stock

    2020-05-26+2,356,5972,356,597 total(indirect: See footnote)
Footnotes (2)
  • [F1]Shares of common stock of the corporation formerly known as Histogen Inc. ("Histogen") were converted into shares of common stock of the Issuer pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of January 28, 2020, by and among the Issuer, Chinook Merger Sub, Inc. and Histogen (the "Merger Agreement"). Pursuant to the terms of the Merger Agreement, each share of Histogen common stock was exchanged for 1.4342 shares of the Issuer's common stock (the "Conversion"). Immediately following the merger, the Issuer changed its name to Histogen Inc. All share numbers reflect the one-for-ten reverse stock split (the "Reverse Split") effected by the Issuer immediately prior to the completion of the merger.
  • [F2]Consists of shares held by Lordship Ventures ("Lordship"). Mr. Jackson is the Chairman of Lordship and has beneficial ownership over the securities owned by Lordship.

Issuer

Histogen Inc.

CIK 0001383701

Entity typeother

Related Parties

1
  • filerCIK 0001810101

Filing Metadata

Form type
4
Filed
May 27, 8:00 PM ET
Accepted
May 28, 7:51 PM ET
Size
6.0 KB